Cerus Corporation Announces Record Fourth Quarter and Full Year 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/28/2026
- Wall St declines as oil spikes after Trump rejects Iran peace proposal
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
- Nvidia’s AI dominance funds historic $150 billion buyback
- MongoDB stock drops 15% as CEO Desai resigns for Meta
- Jefferies cuts Roblox to Underperform, says rally is too optimistic
- Bloom Energy shares fall on Oracle project halt
- Oppenheimer sees AI software winners as focus shifts to ROI
- Exclusive-Activist Jana pushes Fiserv to accelerate cost cuts and tap Palantir
- Cantor Fitzgerald Starts Lexicon Pharmaceuticals (LXRX) at Overweight
- Arm Holdings falls as CFO stock sale weighs on sentiment
Cerus (CERS) Misses Q4 EPS by 1c, Revenues Beat
February 20, 2020 4:02 PM ESTCerus (NASDAQ: CERS) reported Q4 EPS of ($0.12), $0.01 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $26.5 million versus the consensus estimate of $25.3 million.
Recent developments and highlights include:
Total fourth quarter revenue of $26.5 million.Record fourth quarter product revenue of $20.9 million, a 27% increase compared to the prior year quarter.Government contract revenue of $5.6 million.Continued increase in worldwide demand for INTERCEPT kits during the fourth quarter with the calculated number of treatable platelet... More